Is Kamala Sicker With COVID Than the White House Will Admit?

[ExquisiteGerbil]

Is Kamala Harris Sicker With COVID Than the White House Will Admit?

BY STEPHEN GREEN APR 27, 2022 2:14 PM ET





Alleged Vice President Kamala Harris is taking a medication indicated only for high-risk COVID-19 sufferers, according to one source.



Dr. Marty Makary, a Johns Hopkins professor of medicine, says he’s “surprised to learn” that Harris is taking Paxlovid, “a drug reserved for high-risk patients.”



He notes that Harris is “asymptomatic, healthy, and quadruple vaccinated.”



Paxlovid is a brand-new oral antiviral drug developed by Pfizer to treat COVID-19. It received emergency FDA approval in December. A just-published explainer piece from Yale says patients must take the drug “within five days of developing symptoms.”



More:



The FDA authorized Paxlovid for people ages 12 and older who weigh at least 88 pounds. But in order to qualify for a prescription, you must also have had a positive COVID-19 test result and be at high risk for developing severe COVID-19.



We had been told that Harris was asymptomatic and does not appear to be in any risk groups.



This is still all that Harris has had to say about it:

Continued at link

[PurplePuppy]

Kamala’s Press Secretary Let Her Prescription Slip



by Jeff Miller

April 28, 2022



OPINION: This article contains commentary which may reflect the author's opinion



A COVID-19 test on Vice President Kamala Harris came back positive. In its simplest form, this seems inconsequential.



In spite of that, the White House managed to raise eyebrows by announcing her treatment – particularly since she will be the next president. God forbid!  🙏🏻😨


The press secretary for Harris announced on Tuesday that the veep took an antiviral medication that should only be prescribed to those at high risk.



This announcement created questions about how serious Harris’ condition is and how it will affect her at the White House, if at all.



The Los Angeles Times notes that this shouldn’t be a big deal, as Harris is not among high-risk groups.



“Harris, 57, has been vaccinated and boosted twice. The shots greatly diminish the chances of her becoming seriously ill. When former President Trump, 75, was hospitalized with COVID-19 in October 2020, he was at much higher risk, given his age and the lack of available vaccines,” said the report.



Overall, Harris appeared to be doing well, considering that officials said he presented no symptoms. Kirsten Allen, Harris’ press secretary, said she “will isolate and continue to work from the Vice President’s residence” while she is ill.



“The Vice President will return to the White House when she tests negative,” Allen added.



The following was also posted by Allen on Tuesday, though:



“Today, after consultation with her physicians, the Vice President was prescribed and has taken Paxlovid,” Allen declared.

Paxlovid is a brand name of a Pfizer-manufactured antiviral medication that consists of “nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use,” according to the FDA website.



In December, it was granted emergency use authorization – but there’s a catch.



Emergency use authorizations are intended for persons “with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death,” the FDA says on its website.



Marty Makary, a professor at Johns Hopkins University who regularly criticizes the Biden administration’s handling of the Coronavirus, noted that this was unusual:



“Surprised to learn that Kamala Harris who is asymptomatic, healthy, and quadruple vaccinated is getting Paxlovid, a drug reserved for high-risk patients per the FDA label,” he posted on Twitter.

Continued at link